TimothyCRodellMD

Pulmonology • Aspen, CO

Critical Care Medicine, Pleural Disease

Chief Executive Officer Aethlon Medical, Inc.

Join to view full profile

Dr. Rodell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Rodell's full profile

Already have an account?

Office
PO Box 8005
Aspen, CO 81612
Phone+1 720-354-2063
Is this information wrong?

Education & Training

University of ColoradoFellowship, Pulmonary Disease and Critical Care Medicine, 1984 - 1987
University of ColoradoResidency, Internal Medicine, 1980 - 1984
University of North Carolina at Chapel Hill School of MedicineClass of 1980

Certifications & Licensure

CO State Medical License 1981 - 2025

Clinical Trials

Randomized Study of Oral Beclomethasone Dipropionate With Ten Days of Prednisone for Treatment of Gastrointestinal GVHD Start of enrollment: 2001 Jul 01
Completed
Phase 3

Publications & Presentations

PubMed

7 citations
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas Cancer.
Peter Muscarella, Tanios Bekaii-Saab, Kristi McIntyre, Alexander S. Rosemurgy, Sharona Ross, Donald A. Richards, William E. Fisher, Patrick J. Flynn, Alicia Mattson, C...> ;Journal of Pancreatic Cancer. 2021 Mar 23
90 citations
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis
Carolina Boni, Harry L.A. Janssen, Marzia Rossi, Seung Kew Yoon, Andrea Vecchi, Valeria Barili, Eric M. Yoshida, Huy N. Trinh, Timothy C. Rodell, Diletta Laccabue, Ari...> ;Gastroenterology. 2017 Jan 1
20 citations
Whole Recombinant Saccharomyces cerevisiae Yeast Expressing Ras Mutations as Treatment for Patients With Solid Tumors Bearing Ras Mutations: Results From a Phase 1 Trial.
Allen Lee Cohn, Michael A. Morse, Bert H. O'Neil, Samuel Whiting, Claire Coeshott, John Ferraro, Donald Bellgrau, David Apelian, Timothy C. Rodell> ;Journal of Immunotherapy. 2018 Apr 1
10 citations
GI-19007, a Novel Saccharomyces cerevisiae-Based Therapeutic Vaccine against Tuberculosis
Thomas H. King, Crystal A. Shanley, Zhimin Guo, Donald Bellgrau, Timothy C. Rodell, S K Furney, Marcela Henao-Tamayo, Ian M. Orme> ;Clinical and Vaccine Immunology. 2017 Dec 5
119 citations
Randomized phase II study of GS-4774 as a therapeutic vaccine in virally suppressed patients with chronic hepatitis B.
Anna S. Lok, Calvin Q. Pan, Steven Han, Huy N. Trinh, W. Jeffrey Fessel, Timothy C. Rodell, Benedetta Massetto, Lanjia Lin, Anuj Gaggar, G. Mani Subramanian, John G. M...> ;Journal of Hepatology. 2016 Sep 1
4 citations
Construction and Immunogenicity Testing of Whole Recombinant Yeast-Based T-Cell Vaccines
Thomas H. King, Zhimin Guo, Melanie Hermreck, Donald Bellgrau, Timothy C. Rodell> ;Methods in Molecular Biology. 2016 Jan 1
93 citations
Phase I Trial of a Yeast-Based Therapeutic Cancer Vaccine (GI-6301) Targeting the Transcription Factor Brachyury
Christopher R. Heery, B. Harpreet Singh, Myrna Rauckhorst, Jennifer L. Marte, Renee N. Donahue, Italia Grenga, Timothy C. Rodell, William L. Dahut, Philip M. Arlen, Ra...> ;Cancer Immunology Research. 2015 Jun 30
19 citations
Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition a...
Jo A. Tucker, Caroline Jochems, Benjamin Boyerinas, Jonathan K. Fallon, John W. Greiner, Claudia Palena, Timothy C. Rodell, Jeffrey Schlom, Kwong-Yok Tsang> ;Cancer Immunology, Immunotherapy. 2014 Sep 4
74 citations
Safety, tolerability and immunogenicity of GS-4774, a hepatitis B virus-specific therapeutic vaccine, in healthy subjects: A randomized study
Anuj Gaggar, Claire Coeshott, David Apelian, Timothy C. Rodell, Brian R. Armstrong, Gong Shen, G. Mani Subramanian, John G. McHutchison> ;Vaccine. 2014 Sep 3
54 citations
A Whole Recombinant Yeast-Based Therapeutic Vaccine Elicits HBV X, S and Core Specific T Cells in Mice and Activates Human T Cells Recognizing Epitopes Linked to Viral...
Thomas H. King, Charles B. Kemmler, Zhimin Guo, Derrick Mann, Yingnian Lu, Claire Coeshott, Adam J. Gehring, Antonio Bertoletti, Zi Z. Ho, William E. Delaney, Anuj Gag...> ;Plos One. 2014 Jul 22
80 citations
A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease.
David M. Hockenbery, Scott Cruickshank, Timothy C. Rodell, Ted Gooley, Friedrich Schuening, Scott D. Rowley, Donald S. David, Mark Brunvand, Brian Berryman, Sunil Abhy...> ;Blood. 2007 May 15
86 citations
Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins
Aurelia Haller, Georg M. Lauer, Thomas H. King, Charles B. Kemmler, Valerie Fiolkoski, Yingnian Lu, Don Bellgrau, Timothy C. Rodell, David Apelian, Alex Franzusoff, Ri...> ;Vaccine. 2007 Feb 9
48 citations
Yeasts encoding tumour antigens in cancer immunotherapy.
Alex Franzusoff, Richard C. Duke, Thomas H. King, Yingnian Lu, Timothy C. Rodell> ;Expert Opinion on Biological Therapy. 2005 Apr 22
60 citations
Mutation-Selective Tumor Remission with Ras-Targeted, Whole Yeast-Based Immunotherapy
Yingnian Lu, Donald Bellgrau, Lori D. Dwyer-Nield, Alvin M. Malkinson, Richard C. Duke, Timothy C. Rodell, Alex Franzusoff> ;Cancer Research. 2004 Aug 1
109 citations
Treatment of severe systemic inflammatory response syndrome and sepsis with a novel bradykinin antagonist, deltibant (CP-0127). Results of a randomized, double-blind, ...
Alan M. Fein, Gordon R. Bernard, Gerard J. Criner, Eugene Fletcher, James T. Good, William A. Knaus, Howard Levy, George M. Matuschak, Harvey M. Shanies, Robert W. Tay...> ;JAMA. 1997 Feb 12
21 citations
The kallikrein/kinin system and kinin antagonists in trauma
Timothy C. Rodell> ;Immunopharmacology. 1996 Jun 1
36 citations
Pulmonary Oxygen Toxicity and Ischemia-Reperfusion Injury: A Mechanism in Common Involving Xanthine Oxidase and Neutrophils
John E. Repine, J. C. Cheronis, Timothy C. Rodell, Stuart L. Linas, Anita Patt> ;The American Review of Respiratory Disease. 1987 Aug 1
23 citations
Wilms' tumor-aniridia association: Segregation of affected chromosome in somatic cell hybrids, identification of cell surface antigen associated with deleted area, and...
James H. Fisher, York E. Miller, Robert S. Sparkes, J. Brownwyn Bateman, Kathryn A. Kimmel, Thomas E. Carey, Timothy Rodell, Steven A. Shoemaker, Charles H. Scoggin> ;Somatic Cell and Molecular Genetics. 1984 Sep 1
Traumatic brain contusions: a clinical role for the kinin antagonist CP-0127.
Narotam, P. K., Rodell, T. C., Nadvi, S. S., Bhoola, K. D., Troha, J. M., Parbhoosingh, R., van Dellen, J. R.> ;Acta Neurochir (Wien). 1998
15 citations
Endothelial cell xanthine oxidase-derived toxic oxygen metabolites contribute to acute lung injury from neutrophil elastase.
T. C. Rodell, J. C. Cheronis, John E. Repine> ;Chest. 1988 Mar 1
Xanthine oxidase-derived hydrogen peroxide contributes to ischemia reperfusion-induced edema in gerbil brains.
Patt, A., Harken, A. H., Burton, L. K., Rodell, T. C., Piermattei, D., Schorr, W. J., Parker, N. B., Berger, E. M., Horesh, I. R., Terada, L. S.> ;J Clin Invest. 1988 May
72 citations
Xanthine oxidase mediates elastase-induced injury to isolated lungs and endothelium.
T. C. Rodell, J. C. Cheronis, C. L. Ohnemus, Dale Piermattei, John E. Repine> ;Journal of Applied Physiology. 1987 Nov 1
Join now to see all

Press Mentions

Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. As Chief Executive OfficerNovember 3rd, 2020
Aethlon Announces Appointment of Charles J. Fisher, Jr., M.D. As Chief Executive OfficerNovember 3rd, 2020
FDA Approves Aethlon Medical’s IDE Supplement for Covid-19 PatientsJune 19th, 2020
Join now to see all